On December 7, 2022, Association for Clinical Oncology (ASCO) Chief Medical Officer and Executive Vice President Julie Gralow MD, FACP, FASCO, attended a reception on Capitol Hill hosted by the One Voice Against Cancer Coalition and the House Cancer Caucus, to welcome former ASCO President Monica Bertagnolli, MD, FACS, FASCO, to her new role as Director of the National Cancer Institute (NCI).
“Dr. Bertagnolli is a powerful force for positive change and the perfect choice to lead NCI at this critical time, to guide innovation and the future of cancer care and research. We look forward to many years of collaboration,” remarked Dr. Gralow.
Monica Bertagnolli, MD, FACS, FASCO
Julie Gralow MD, FACP, FASCO
Representatives Derek Kilmer (D-WA), Brian Higgins (D-NY), and Mike Kelly (R-PA), Co-Chairs of the House Cancer Caucus, joined the reception and shared their well wishes and congratulations.
“We have a great new leader who is about to take on the responsibility of the National Cancer Institute,” said Rep. Higgins. “We pledge to work with you—Republicans, Democrats, all of us—toward the goal of one day eliminating all suffering and death due to cancer.”
“We’re thrilled to have you leading the charge and working not just for NCI but working to advance the Cancer Moonshot and to end cancer as we know it,” said Rep. Kilmer.
“You wear a cape,” said Rep. Kelly, summarizing an evening of gratitude and recognition of Dr. Bertagnolli’s previous work and the work to come.
The Association looks forward to working with Dr. Bertagnolli and continued collaborations with NCI.
© 2022. American Society of Clinical Oncology. All rights reserved.
